Lincoln Pharmaceuticals Limited (BOM:531633)

Lincoln Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	9,077	11,047	11,725	6,784	6,230	4,494
Market Cap Growth	-43.70%	-5.78%	72.84%	8.89%	38.64%	67.94%
Enterprise Value	6,759	9,087	10,027	5,679	5,224	3,624
Last Close Price	453.20	549.78	582.16	335.85	306.89	220.85
PE Ratio	11.35	13.42	12.57	9.31	8.98	7.22
Forward PE	-	13.25	13.25	13.25	13.25	13.25
PS Ratio	1.44	1.77	2.02	1.33	1.32	1.06
PB Ratio	1.27	1.65	1.98	1.35	1.44	1.23
P/TBV Ratio	1.27	1.65	1.98	1.35	1.44	1.23
P/FCF Ratio	11.56	14.93	49.39	27.13	20.36	7.43
P/OCF Ratio	9.04	11.88	18.55	17.28	8.18	6.49
PEG Ratio	-	0.53	0.53	0.53	0.53	0.53
EV/Sales Ratio	1.07	1.46	1.73	1.11	1.11	0.85
EV/EBITDA Ratio	6.71	8.86	10.02	6.34	5.46	4.16
EV/EBIT Ratio	7.75	10.13	11.19	7.05	5.96	4.54
EV/FCF Ratio	8.61	12.28	42.23	22.71	17.07	5.99
Debt / Equity Ratio	0	-	0.00	0.00	0.01	0.00
Debt / EBITDA Ratio	0.00	-	0.01	0.02	0.02	0.01
Debt / FCF Ratio	0.00	-	0.05	0.08	0.07	0.01
Asset Turnover	0.77	0.83	0.90	0.91	0.96	1.01
Inventory Turnover	3.63	3.81	3.85	3.44	3.72	4.29
Quick Ratio	3.47	3.41	3.41	3.39	2.56	2.74
Current Ratio	4.71	4.71	4.74	5.09	3.90	4.07
Return on Equity (ROE)	11.81%	13.02%	17.04%	15.59%	17.36%	18.31%
Return on Assets (ROA)	6.67%	7.49%	8.70%	8.97%	11.11%	11.85%
Return on Invested Capital (ROIC)	13.33%	14.75%	16.32%	16.32%	21.41%	21.79%
Return on Capital Employed (ROCE)	11.80%	13.00%	14.70%	15.60%	19.80%	21.20%
Earnings Yield	8.81%	7.45%	7.96%	10.75%	11.13%	13.85%
FCF Yield	8.65%	6.70%	2.02%	3.69%	4.91%	13.47%
Dividend Yield	0.39%	0.33%	0.31%	0.45%	0.49%	0.68%
Payout Ratio	4.48%	4.38%	3.22%	4.12%	4.33%	-
Buyback Yield / Dilution	0.01%	-	-	-	-	-0.15%
Total Shareholder Return	0.41%	0.33%	0.31%	0.45%	0.49%	0.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.